BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 24955861)

  • 1. Effects of brexpiprazole, a novel serotonin-dopamine activity modulator, on phencyclidine-induced cognitive deficits in mice: a role for serotonin 5-HT1A receptors.
    Yoshimi N; Fujita Y; Ohgi Y; Futamura T; Kikuchi T; Hashimoto K
    Pharmacol Biochem Behav; 2014 Sep; 124():245-9. PubMed ID: 24955861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of dizocilpine-induced social recognition deficits in mice by brexpiprazole, a novel serotonin-dopamine activity modulator.
    Yoshimi N; Futamura T; Hashimoto K
    Eur Neuropsychopharmacol; 2015 Mar; 25(3):356-64. PubMed ID: 25600995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: role of serotonin 5-HT1A receptors.
    Hagiwara H; Fujita Y; Ishima T; Kunitachi S; Shirayama Y; Iyo M; Hashimoto K
    Eur Neuropsychopharmacol; 2008 Jun; 18(6):448-54. PubMed ID: 18164909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brexpiprazole II: antipsychotic-like and procognitive effects of a novel serotonin-dopamine activity modulator.
    Maeda K; Lerdrup L; Sugino H; Akazawa H; Amada N; McQuade RD; Stensbøl TB; Bundgaard C; Arnt J; Kikuchi T
    J Pharmacol Exp Ther; 2014 Sep; 350(3):605-14. PubMed ID: 24947464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of neurite outgrowth by brexpiprazole, a novel serotonin-dopamine activity modulator: a role for serotonin 5-HT1A and 5-HT2A receptors.
    Ishima T; Futamura T; Ohgi Y; Yoshimi N; Kikuchi T; Hashimoto K
    Eur Neuropsychopharmacol; 2015 Apr; 25(4):505-11. PubMed ID: 25687838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brexpiprazole I: in vitro and in vivo characterization of a novel serotonin-dopamine activity modulator.
    Maeda K; Sugino H; Akazawa H; Amada N; Shimada J; Futamura T; Yamashita H; Ito N; McQuade RD; Mørk A; Pehrson AL; Hentzer M; Nielsen V; Bundgaard C; Arnt J; Stensbøl TB; Kikuchi T
    J Pharmacol Exp Ther; 2014 Sep; 350(3):589-604. PubMed ID: 24947465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin (5-HT)1A receptor agonism and 5-HT7 receptor antagonism ameliorate the subchronic phencyclidine-induced deficit in executive functioning in mice.
    Rajagopal L; Massey BW; Michael E; Meltzer HY
    Psychopharmacology (Berl); 2016 Feb; 233(4):649-60. PubMed ID: 26558619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blonanserin reverses the phencyclidine (PCP)-induced impairment in novel object recognition (NOR) in rats: role of indirect 5-HT(1A) partial agonism.
    Horiguchi M; Meltzer HY
    Behav Brain Res; 2013 Jun; 247():158-64. PubMed ID: 23538066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged reversal of the phencyclidine-induced impairment in novel object recognition by a serotonin (5-HT)1A-dependent mechanism.
    Horiguchi M; Miyauchi M; Neugebauer NM; Oyamada Y; Meltzer HY
    Behav Brain Res; 2016 Mar; 301():132-41. PubMed ID: 26342283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of quetiapine on phencyclidine-induced cognitive deficits in mice: a possible role of alpha1-adrenoceptors.
    Tanibuchi Y; Fujita Y; Kohno M; Ishima T; Takatsu Y; Iyo M; Hashimoto K
    Eur Neuropsychopharmacol; 2009 Dec; 19(12):861-7. PubMed ID: 19656663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phencyclidine-induced cognitive deficits in mice are ameliorated by subsequent subchronic administration of donepezil: role of sigma-1 receptors.
    Kunitachi S; Fujita Y; Ishima T; Kohno M; Horio M; Tanibuchi Y; Shirayama Y; Iyo M; Hashimoto K
    Brain Res; 2009 Jul; 1279():189-96. PubMed ID: 19433073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of presynaptic 5-HT
    Mombereau C; Arnt J; Mørk A
    Pharmacol Biochem Behav; 2017 Feb; 153():141-146. PubMed ID: 28057524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of tropisetron: role of alpha7 nicotinic receptors.
    Hashimoto K; Fujita Y; Ishima T; Hagiwara H; Iyo M
    Eur J Pharmacol; 2006 Dec; 553(1-3):191-5. PubMed ID: 17094961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute effects of brexpiprazole on serotonin, dopamine, and norepinephrine systems: an in vivo electrophysiologic characterization.
    Oosterhof CA; El Mansari M; Blier P
    J Pharmacol Exp Ther; 2014 Dec; 351(3):585-95. PubMed ID: 25225185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of novel antipsychotics with mixed D(2) antagonist/5-HT(1A) agonist properties on PCP-induced social interaction deficits in the rat.
    Bruins Slot LA; Kleven MS; Newman-Tancredi A
    Neuropharmacology; 2005 Dec; 49(7):996-1006. PubMed ID: 16009387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of 5-HT1A receptors in phencyclidine (PCP)-induced novel object recognition (NOR) deficit in rats.
    Horiguchi M; Meltzer HY
    Psychopharmacology (Berl); 2012 May; 221(2):205-15. PubMed ID: 22227609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aripiprazole ameliorates phencyclidine-induced impairment of recognition memory through dopamine D1 and serotonin 5-HT1A receptors.
    Nagai T; Murai R; Matsui K; Kamei H; Noda Y; Furukawa H; Nabeshima T
    Psychopharmacology (Berl); 2009 Jan; 202(1-3):315-28. PubMed ID: 18679658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the novel selective alpha7 nicotinic receptor agonist SSR180711.
    Hashimoto K; Ishima T; Fujita Y; Matsuo M; Kobashi T; Takahagi M; Tsukada H; Iyo M
    Biol Psychiatry; 2008 Jan; 63(1):92-7. PubMed ID: 17601496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma-1 receptors.
    Hashimoto K; Fujita Y; Iyo M
    Neuropsychopharmacology; 2007 Mar; 32(3):514-21. PubMed ID: 16495935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effects of metabotropic glutamate receptor 5 positive allosteric modulator CDPPB on phencyclidine-induced cognitive deficits in mice.
    Horio M; Fujita Y; Hashimoto K
    Fundam Clin Pharmacol; 2013 Oct; 27(5):483-8. PubMed ID: 22594375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.